Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001401914-20-000050
Filing Date
2020-04-22
Accepted
2020-04-22 16:17:52
Documents
5
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14aproxyadditionalmate.htm DEFA14A 31465
2 additionalproxymaterials001.jpg GRAPHIC 96744
3 additionalproxymaterials002.jpg GRAPHIC 123683
4 additionalproxymaterials003.jpg GRAPHIC 48552
5 additionalproxymaterials004.jpg GRAPHIC 27110
  Complete submission text file 0001401914-20-000050.txt   440683
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 20808133
SIC: 2834 Pharmaceutical Preparations